Schedule 13D ownership disclosure

Iterum Therapeutics plc

Security class unavailable · CUSIP: 00BF3W0Q3

Event date: 2020-06-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-070361
Form type
SC 13D/A
Filer
Iterum Therapeutics plc
CIK
CIK 1659323
Filed
Jun 05, 2020
Reporting period
Jun 02, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub